Brandywine Global Investment Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.29M Sell
125,210
-4,700
-4% -$122K 0.02% 423
2025
Q3
$2.94M Sell
129,910
-4,800
-4% -$98.9K 0.02% 442
2025
Q2
$2.68M Buy
+134,710
New +$2.63M 0.02% 456
2024
Q1
Sell
-82,253
Closed -$2.38M 719
2023
Q4
$2.38M Sell
82,253
-8,614
-9% -$230K 0.02% 536
2023
Q3
$2.43M Buy
+90,867
New +$3.1M 0.02% 521

Other funds holding FLGT

Brandywine Global Investment Management's FLGT Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its Fulgent Genetics (FLGT) stake by 3.6% in Q4 2025, selling an estimated $122K and leaving 125,210 shares worth $3.29M. The position accounts for 0.02% of the portfolio, ranked #423.

Brandywine Global Investment Management first reported a position in FLGT in Q3 2023 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Brandywine Global Investment Management held 125,210 shares of Fulgent Genetics worth $3.29M as of Q4 2025.
  • Brandywine Global Investment Management sold 4,700 Fulgent Genetics shares in Q4 2025, an estimated $122K.
  • Fulgent Genetics made up 0.02% of Brandywine Global Investment Management's portfolio in Q4 2025, its #423 holding.
  • Brandywine Global Investment Management first reported a position in Fulgent Genetics in Q3 2023 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.